OpenEvidience是供医生使用的AI工具,筹集了2亿美元,价值60亿美元,用于扩大临床决策支持。 OpenEvidence, an AI tool for doctors, raised $200 million, valuing it at $6 billion to expand its clinical decision support.

公开证据(OpenEvience)是一个医疗AI平台, 通常被称为“医生的ChatGPT”, 已获得2亿美元的资金, 公司价值为60亿美元。 OpenEvidence, a medical AI platform often described as "ChatGPT for doctors," has secured $200 million in funding, valuing the company at $6 billion. 该回合由著名投资者领导,标志着该公司的一个重要里程碑,目的是协助保健专业人员提供循证临床决策支持。 The round, led by prominent investors, marks a significant milestone for the company aiming to assist healthcare professionals with evidence-based clinical decision support. 这笔资金将支持扩大其由AI驱动的工具,提高数据准确性,并扩大美国医院和诊所的采用范围。 The funding will support expanding its AI-driven tools, enhancing data accuracy, and broadening adoption across U.S. hospitals and clinics.